Clovis Oncology, Inc. CLVS
Set alert
0.08 0.00 0.00%
At close · Dec 20
0.078 Day range 0.0977
52-week range unavailable
- Open
- 0.0808
- Prev close
- 0.0812
- Mkt cap
- 0
- Vol
- 24.21M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.078
- High
- 0.0977
- Forward P/E
- -0.10
- Beta
- 0.22
- Short ratio
- 4.63
- Inst. own
- 25.90%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2022
- 50-d avg
- 0.517402
- 200-d avg
- 1.26
- 1y target
- 2.00
1Y chart
Events in this range
- Feb 23, 2022Earnings: —; estimate -0.6; surprise —%
- May 4, 2022Earnings: —; estimate -0.43; surprise —%
- May 5, 2022Rating: HC Wainwright & Co. · — → Buy
- May 6, 2022Downgrade: HC Wainwright & Co. · Buy → Neutral
- Aug 8, 2022Earnings: —; estimate -0.42; surprise —%
- Nov 9, 2022Earnings: —; estimate -0.42; surprise —%
- Nov 10, 2022Downgrade: JP Morgan · Neutral → Underweight
Signals (31)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Dec 5, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 28, 2022 | 3 years ago |
| RSI: Oversold | Nov 9, 2022 | 3 years ago |
| MACD: Sell Signal | Oct 31, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 28, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 12, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 29, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 8, 2022 | 4 years ago |
| SMA: Bearish | Aug 8, 2022 | 4 years ago |
| MACD: Sell Signal | Jul 15, 2022 | 4 years ago |
| RSI: Overbought | Jul 8, 2022 | 4 years ago |
| RSI: Overbought | Jun 30, 2022 | 4 years ago |
| RSI: Overbought | Jun 23, 2022 | 4 years ago |
| SMA: Bullish | Jun 21, 2022 | 4 years ago |
| RSI: Overbought | Jun 21, 2022 | 4 years ago |
| MACD: Buy Signal | May 26, 2022 | 4 years ago |
| RSI: Oversold | May 6, 2022 | 4 years ago |
| SMA: Bearish | May 4, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 18, 2022 | 4 years ago |
| RSI: Overbought | Apr 1, 2022 | 4 years ago |
| SMA: Bullish | Mar 31, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 18, 2022 | 4 years ago |
| MACD: Sell Signal | Mar 14, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 9, 2022 | 4 years ago |
| MACD: Sell Signal | Mar 7, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 8, 2022 | 4 years ago |
| RSI: Oversold | Jan 26, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 20, 2022 | 4 years ago |
Valuation
P/E -1.2×
FY 2012 5y median -1.4× FY 2021
P/S 2.2×
FY 2012 5y median 3.9× FY 2021
P/B -1.2×
FY 2012 5y median -1.2× FY 2021
P/FCF -1.7×
FY 2012 5y median -1.7× FY 2021
EV/EBITDA -7.2×
FY 2012 5y median -3.9× FY 2021
EV/Sales 5.5×
FY 2012 5y median 7.6× FY 2021
FCF Yield -59.8%
FY 2012 5y median -59.8% FY 2021
Profitability
Gross Margin 73.9%
FY 2012 5y median 75.7% FY 2021
Operating Margin -156.8%
FY 2012 5y median -263.4% FY 2021
Net Margin -177.8%
FY 2012 5y median -280.0% FY 2021
ROE 94.9%
FY 2012 5y median 94.9% FY 2021
ROIC -66.3%
FY 2012 5y median -66.3% FY 2021
ROA -55.9%
FY 2012 5y median -55.9% FY 2021
Growth (YoY)
Revenue -9.6%
FY 2012 FY 2021
Operating Income 22.8%
FY 2012 FY 2021
EPS (diluted) 50.2%
FY 2012 FY 2021
Free Cash Flow 24.8%
FY 2012 FY 2021
Financial Health
Current Ratio 1.6×
FY 2012 5y median 2.8× FY 2021
Quick Ratio 1.5×
FY 2012 5y median 2.6× FY 2021
Debt / Equity -2.3×
FY 2012 5y median -2.3× FY 2021
Net Debt / EBITDA -4.3×
FY 2012 5y median -1.1× FY 2021
Interest Coverage -7.4×
FY 2012 5y median -22.8× FY 2021
Dividends
Dividend Yield 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012 5y median 0.0% FY 2021
Annual · latest fiscal year ends 2021-12-31